A study led by the University of Birmingham found that vancomycin, a commonly used antibiotic for diarrhea, could effectively ...

An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...

After the completion of any form of exercise, or from any injury to ill, the focus is usually placed on rest, physical ...

During this stage, you can expect to experience inflammation, swelling, heat, and pain. The body begins to rebuild the wounded skin during proliferation, the third healing phase. Proliferation ...

An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.

Results published in the Journal of Crohn's and Colitis revealed that an antibiotic called vancomycin may also be effective ...

Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz). In January, the FDA approved Omvoh for moderately to severely active Crohn's ...

Eli Lilly presents positive results from VIVID-2 open-label extension study of Omvoh to treat Crohn's disease at Crohn's and Colitis Congress: Indianapolis Monday, February 10, 20 ...

Eli Lilly and Company (NYSE: LLY) announced results from the VIVID-2 open-label extension study, which showed the majority of patients with moderately to severely active Crohn's disease receiving two ...

You're invited to publicize your 2024–2025 new product introductions in LCGC International. For our 2025 review, you may submit any product launched between May 2024 and March 2025. We have four forms ...